TrialThe New England journal of medicine2020
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
Cheryl Keech et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
763 papers cite itlatest 60 shown
this paperpooled ittrialcites it